Core Insights - Daxor Corporation presented new clinical data on capillary leak detection at the SCCM 2026 Critical Care Congress, highlighting the accuracy of its Blood Volume Analyzer (BVA) compared to traditional clinical scoring methods [1][2]. Group 1: Study Findings - The study titled "Mechanistic Specificity of Capillary Leak Indices: Validation in Heart Failure as a Negative Control" focused on the relationship between traditional clinical scoring methods and direct in-vivo measurement of albumin escape using Daxor's BVA [2]. - The BVA system measured the Albumin Escape Rate (AER), revealing significantly elevated rates (median 20% per hour) in patients, even when traditional clinical scores were low [7]. - The research indicated that clinical indices showed weak correlations with actual albumin escape, suggesting traditional scores may overlook significant vascular leakage in heart failure patients [7]. Group 2: Commercial Significance - Daxor's BVA system is positioned as the sole provider of objective, real-time albumin leak rate and volume measures, enhancing clinical benefits in critical care and heart failure markets [5]. - The unique combination of accurate volume measurement and leak rate analysis is essential for proper treatment and precision medicine [5]. - The research validates Daxor's BVA as a unique diagnostic tool that provides essential data for individualized patient care [6]. Group 3: Industry Context - Daxor Corporation addresses a significant healthcare challenge, the inability to precisely measure blood volume, which can lead to suboptimal care and increased hospital stays for conditions like heart failure [8]. - With 50 years of experience, Daxor manufactures and distributes its FDA-cleared BVA diagnostic, which offers real-time, precise data to improve patient outcomes and enhance efficiencies in value-based healthcare [8].

Core Viewpoint - Maxus Mining Inc. has successfully acquired a 100% legal and beneficial interest in the Alturas West Property, enhancing its position in the antimony sector and allowing for full control over exploration and development activities [1][2][7]. Project Overview - The Alturas Antimony Project consists of two claim blocks, Alturas West and Alturas East, located in the historic Alps-Alturas antimony mine area within the Slocan Mining District [3]. - The project features a 1,300-meter mineralized corridor with quartz veins containing stibnite mineralization [3]. Historical Production - Historical production from the Alps-Alturas mine averaged approximately 57.2% antimony, with grades reaching up to 59.5% Sb [4]. Transaction Highlights - The completion of the acquisition fulfills all obligations under the Property Option Agreement with Eminence Minerals Ltd., securing full ownership of Alturas West [2][8]. - This milestone strengthens the company's strategic positioning in the antimony sector [7]. Next Steps - The company will focus on advancing exploration planning, including data integration, target refinement, and preparation for drilling programs [6][9]. - Full ownership allows for flexibility in advancing exploration, permitting, and development initiatives across the broader project [8]. Portfolio Overview - Maxus Mining's portfolio includes approximately 15,098 hectares of prospective terrain across British Columbia, with a significant focus on antimony projects [14]. - The flagship Alturas Antimony Project has reported high-grade naturally occurring antimony values, with recent discoveries showing grades up to 69.98% Sb [15].

Core Viewpoint - AMC Networks Inc. has announced the redemption of all outstanding 10.25% Senior Secured Notes due 2029, set for April 6, 2026, at a redemption price of 105.125% of the principal amount plus accrued interest [1]. Group 1: Redemption Details - The company has instructed U.S. Bank Trust Company to distribute a notice of redemption to all registered holders of the Notes on March 26, 2026 [2]. - The redemption price includes a premium of 5.125% over the principal amount of the Notes being redeemed [1]. Group 2: Company Overview - AMC Networks is a prominent entity in the entertainment industry, known for creating and curating celebrated series and films across various brands [3]. - The company's portfolio includes streaming services such as AMC+, Acorn TV, Shudder, and cable networks like AMC and BBC AMERICA, along with film distribution labels [3]. - AMC Networks operates its in-house studio, AMC Studios, which is responsible for original franchises like The Walking Dead Universe [3].

Core Insights - FactSet has announced a significant expansion of its AI capabilities with the beta rollout of AI-enabled Document Search to over 85,000 users, enhancing access to unstructured data for financial professionals [1][2] - The company aims to set the standard for trustworthy AI adoption in the financial sector, emphasizing compliance and auditable intelligence [2] Recent AI Advancements - Document Search is the latest large-scale beta initiative, following several AI innovations that aim to create a unified, multi-interface platform for clients [2] - The platform includes features such as LLM capabilities and compliance safeguards, ensuring security and reliability [2] Document Search Features - Document Search allows users to extract insights from various unstructured data sources, including transcripts and earnings calls, while maintaining auditability and integration [3] - It provides rapid, source-linked results from trusted sources, minimizing risks associated with precision [4] - The tool includes a comparison grid for benchmarking and a natural language AI agent for instant Q&A and summarized insights [4] Rollout and Future Developments - The public beta began in January 2026, with a phased global release planned through late spring 2026, following positive initial feedback [5] - FactSet is committed to continuous improvement, including the development of secure broker research summaries to enhance discoverability while protecting intellectual property [5] Company Overview - FactSet offers enterprise data and information solutions, integrating proprietary financial data and third-party sources to deliver tailored solutions across various sectors [7] - The company serves over 9,000 global clients and more than 239,000 individual users, leveraging advanced data connectivity and AI tools to enhance productivity and decision-making [7]

Core Viewpoint - Kratos Defense & Security Solutions, Inc. has been awarded a contract by the Naval Surface Warfare Center for the production and delivery of Oriole solid rocket motors and Thrust Vector Control nozzle kits, with a total potential value of approximately $39 million for solid rockets and $10 million for TVC kits [1][2][3] Group 1: Contract Details - The contract includes a base award for the production of up to 36 Oriole solid rocket motors and three Thrust Vector Control nozzle kits [1] - If all options are exercised, the total contract value for solid rockets will reach $39,077,237, while the option for TVC production kits is valued at $10,136,009 [1] Group 2: Product and Capability - The Oriole rocket system is designed as an affordable solution for the Navy's suborbital target and experimental hypersonic test requirements, emphasizing rapid delivery and fielding [2] - Kratos has a proven track record in delivering Oriole rocket systems, which supports robust test and evaluation schedules for national security [2][3] Group 3: Company Strategy and Position - The company emphasizes its commitment to providing affordable, rapid turn-key launch vehicle solutions to the Department of War and Navy, reinforcing its long-standing partnership with NSWC PHD [3] - Kratos focuses on making internal investments to deliver first-to-market national security hardware, which is central to its growth strategy [4] - The company aims to pursue program and contract opportunities where it has a high probability of winning, while also considering partnerships with larger traditional system integrators when necessary [4]

Core Insights - VenHub Global, Inc. has been recognized in Fast Company's 2026 Most Innovative Companies list, ranking in the top ten in the Retail category, highlighting its leadership in fully autonomous Smart Store technology [1][2] Company Overview - VenHub designs and deploys fully autonomous Smart Stores that operate 24/7 without on-site staff, integrating robotics, real-time inventory tracking, and mobile-based checkout to enhance retail efficiency [5] - The company is headquartered in Las Vegas, Nevada, and aims to provide secure, high-efficiency retail solutions in high-traffic environments [5] Innovation and Deployment - The recognition from Fast Company underscores VenHub's transition from concept to live deployment of fully autonomous retail Smart Stores, which are designed for rapid deployment in high-traffic and retail-deprived locations [2][3] - VenHub's Smart Stores enable operators to deploy stores faster and operate more efficiently, addressing critical needs for convenience, labor efficiency, and high-margin operations [3][4] Market Demand and Growth - With active deployments and a growing pipeline of national and international demand, VenHub is scaling a new category of retail that allows partners to unlock incremental revenue from underutilized real estate while reducing operating complexity and costs [4]

Core Insights - GCL Global Holdings Ltd is launching a new interactive game titled "Island of Hearts," which combines full-motion video, player-driven dialogue, and mini-games, targeting the growing market for narrative-driven gaming experiences [3][6]. Company Overview - GCL Global Holdings Ltd is a leading provider of games and entertainment, focusing on the Asian gaming market through its subsidiaries, including 4Divinity and Titan Digital Media [10][12]. - The company aims to unite people through its ecosystem of content and hardware, enabling creators to deliver engaging experiences to gaming communities worldwide [10]. Product Details - "Island of Hearts" is set in a luxury resort in Phuket, Thailand, where players navigate personal challenges and engage with a cast of characters through branching dialogues and mini-challenges [4][5]. - The game features seven popular female content creators from Asia, enhancing its appeal through influencer-led casting [5][6]. - It includes a full Mandarin Chinese dub alongside the original English performances, broadening its accessibility [7]. Market Context - The game enters a rapidly expanding segment of the gaming market, specifically the FMV (full-motion video) genre, which has seen a resurgence due to consumer demand for character-driven storytelling [6]. - GCL's strategy leverages the popularity of social media influencers to reach a wider audience across gaming and digital media [6]. Marketing and Merchandise - Alongside the digital release, GCL is offering exclusive merchandise bundles for pre-order, which include game codes and collectible items [8][9]. - The game is priced at $13.49 with a limited-time 10% launch discount, aiming to attract early adopters [3][9].

Core Insights - Gabelli Funds will host the 12th Annual Waste & Environmental Services Symposium on April 9th, 2026, in Midtown Manhattan, focusing on industry dynamics, trends, and sustainability investing [1] Group 1: Event Details - The symposium will feature discussions with leading companies and organizations in the waste and environmental services sectors [1] - Attendees can participate in one-on-one meetings with management teams upon request, and the event will also be available via webcast for those unable to attend in person [2] Group 2: Presenting Companies - Notable companies presenting at the symposium include Aduro Clean Technologies Inc., Casella Waste Systems, Inc., CECO Environmental Corp., Greif, Inc., Lightbridge Corporation, Loop Industries, Inc., One and One Green Technologies, Inc., Perma-Fix Environmental Services, Inc., Republic Services, Inc., SECURE Waste Infrastructure Corp., and Waste Connections, Inc. [3]

Core Insights - Quantum BioPharma Ltd. has appointed Dr. Salvatore Napoli as Principal Investigator for its Phase 2 clinical trial of Lucid-21-302 (Lucid-MS), a therapy targeting demyelination in Multiple Sclerosis (MS) [1][4] Company Overview - Quantum BioPharma is focused on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders, with a lead compound, Lucid-MS, aimed at preventing and reversing myelin degradation [5] - The company retains a 19.86% ownership stake in Unbuzzd Wellness Inc. and has a royalty agreement that includes 7% of sales until reaching $250 million, after which it drops to 3% [5] Clinical Development - The company plans to submit an Investigational New Drug (IND) application for Lucid-MS to the FDA, which will include the design of the Phase 2 trial [3] - The Phase 2 trial will assess the efficacy, safety, and tolerability of Lucid-MS in MS patients, pending regulatory approval [3] Expert Involvement - Dr. Salvatore Napoli is a recognized expert in MS with over 20 years of experience and has held significant academic positions, including at Harvard Medical School [2] - His expertise is expected to be crucial in advancing the clinical evaluation of Lucid-MS, addressing significant unmet medical needs in MS [4]

Core Insights - Geron Corporation has appointed Patricia S. Andrews and Constantine Chinoporos to its Board of Directors, enhancing its leadership team with experienced industry veterans [1][2][3] Company Overview - Geron Corporation is a commercial-stage biopharmaceutical company focused on changing the course of blood cancer, with its first-in-class telomerase inhibitor RYTELO (imetelstat) approved in the U.S. and EU for treating certain adult patients with lower-risk myelodysplastic syndromes with transfusion-dependent anemia [4] - The company is conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis and other hematologic malignancies [4] Leadership Experience - Patricia S. Andrews brings extensive experience, having served in various leadership roles, including CEO of Sumitomo Pharma Oncology and positions at Glenmark Pharmaceuticals and Oncolytics Biotech [2][3] - Constantine Chinoporos has held senior positions in business development and corporate finance at companies like Applied Therapeutics and Albireo Pharmaceuticals, and currently serves as a strategic advisor to Apollo Therapeutics [3] Strategic Focus - The new board members are expected to provide valuable insights as Geron executes its strategic priorities and drives commercial growth for RYTELO [2] - Both Andrews and Chinoporos expressed their commitment to supporting Geron's focused commercial strategy and long-term growth objectives [2][3]